Crossmark

The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review

Published Online: 2023-12-26

Published Print: 2024-04

Authors

Tobaiqy, Mansour https://orcid.org/0000-0002-4292-0900
Helmi, Nawal https://orcid.org/0000-0001-5460-1440
MacLure, Katie https://orcid.org/0000-0003-0686-948X
Saade, Sylvia
License Information

Text and Data Mining valid from 2023-12-26

Version of Record valid from 2023-12-26
More Information

Article History

Received: 10 November 2023

Accepted: 13 November 2023

First Online: 26 December 2023

Conflicts of interest

: The authors have none to declare.

Document is current